Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.355 USD | -1.81% | -3.21% | +1.12% |
Apr. 24 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
Mar. 25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
- Stock Market
- Equities
- PGEN Stock
- News Precigen, Inc.
- MarketScreener Editorial Features